Epidemiology of ANCA-associated Vasculitis (Q43406200)

23 November 2017

title

Epidemiology of ANCA-associated vasculitis (English)

1 reference

23 November 2017

Epidemiology of ANCA-associated Vasculitis (English)

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

17 June 2024

1 reference

Eleana Ntatsaki

1

1 reference

23 November 2017

Richard A. Watts

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688243

17 June 2024

David G. I. Scott

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688243

17 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20688243

17 June 2024

publication date

15 June 2010

1 reference

full work available at URL

23 November 2017

https://api.elsevier.com/content/article/PII:S0889857X10000384?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

https://api.elsevier.com/content/article/PII:S0889857X10000384?httpAccept=text/plain

17 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Rheumatic Diseases Clinics of North America

17 June 2024

published in

1 reference

23 November 2017

volume

36

1 reference

23 November 2017

issue

3

1 reference

23 November 2017

page(s)

447-461

1 reference

The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis

23 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

17 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis.

17 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

17 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Evaluation of a new algorithm in classification of systemic vasculitis.

17 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales

17 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions

17 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa.

17 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Prevalence and incidence of Wegener's granulomatosis in the UK general practice research database

17 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins

17 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Incidence of Wegener's granulomatosis in children.

17 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Epidemiology of Wegener's granulomatosis in northern Norway.

17 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register

17 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Primary vasculitis in a Norwegian community hospital: a retrospective study.

17 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects.

17 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Incidence of primary systemic vasculitides in Vilnius: a university hospital population based study

17 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Wegener's granulomatosis: epidemiological and clinical features in a South Australian study.

17 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe

17 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany

17 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources

17 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Renal vasculitis in Japan and the UK--are there differences in epidemiology and clinical phenotype?

17 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region

17 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Wegener's granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient.

17 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Wegener's granulomatosis in India: not so rare

17 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate

17 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan.

17 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease

17 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

The Wegener's granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping

17 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Seasonal variation in the onset of Wegener's granulomatosis, polyarteritis nodosa and giant cell arteritis

17 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Are environmental factors important in primary systemic vasculitis? A case-control study

17 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation?

17 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence

17 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis

17 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis

17 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Occupational risk factors for Wegener's granulomatosis: a case-control study

17 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Silicon exposure and vasculitis.

17 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study

17 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Wegener's granulomatosis: role of environmental exposures

17 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Hydrocarbon exposure and glomerulonephritis due to systemic vasculitis

17 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Wegener's granulomatosis: Possible role of environmental agents in its pathogenesis

17 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

The kidney in periarteritis nodosa

17 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

The spectrum of renal disease associated with microscopic polyangiitis and classic polyarteritis nodosa in Kuwait.

17 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome

17 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies

17 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Significantly high regional morbidity of MPO-ANCA-related angitis and/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan).

17 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Churg-Strauss syndrome: retrospective study in Burgundian population in France in past 10 years

17 June 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Virus-associated vasculitides

17 June 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Churg-strauss syndrome in patients treated with omalizumab

17 June 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database

17 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Asthma drug use and the development of Churg-Strauss syndrome (CSS).

17 June 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study.

17 June 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Epidemiology of autoimmune diseases in Denmark

17 June 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden.

17 June 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.04.002

17 June 2024

Identifiers

1 reference

23 November 2017

1 reference